 <h1>Trodelvy Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>sacituzumab govitecan</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about sacituzumab govitecan. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Trodelvy.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to sacituzumab govitecan: intravenous powder for injection</i></p><h3>Warning</h3><p>Sacituzumab govitecan affects your immune system.  You may get infections more easily, even serious or fatal infections. Tell your doctor if you have a fever, chills, pain or burning when you urinate, cough, or trouble breathing.</p><p>Sacituzumab govitecan commonly causes diarrhea. Severe diarrhea can lead to dehydration, which may require medical treatment.</p><p>Tell your doctor right away the first time you have diarrhea while receiving this medicine, or if you have black or bloody stools, if you feel light-headed, if you can't keep liquids down because of vomiting, or if you can't get your diarrhea to stop within 24 hours.</p><p>This medicine can cause severe or life-threatening allergic reactions.</p><p>Get emergency medical help if you have signs of an allergic reaction:  hives; difficult breathing; swelling of your face, lips, tongue, or throat.</p><p>Some side effects may occur during the injection or within 24 hours afterward.  Tell your caregiver if you feel dizzy, light-headed, itchy, sweaty, or have a fever, chills, trouble breathing, or swelling in your face or throat.</p><p>You may get infections more easily, even serious or fatal infections.  Call your doctor right away if you have:</p><ul>
<li>
<p>pain or burning when you urinate;</p>
</li>
<li>
<p>low red blood cells (anemia)--pale skin, unusual tiredness, feeling light-headed or short of breath, cold hands and feet; or</p>
</li>
<li>
<p>low white blood cell counts--fever, mouth sores, skin sores, sore throat, cough, trouble breathing.</p>
</li>
</ul><p>pain or burning when you urinate;</p><p>low red blood cells (anemia)--pale skin, unusual tiredness, feeling light-headed or short of breath, cold hands and feet; or</p><p>low white blood cell counts--fever, mouth sores, skin sores, sore throat, cough, trouble breathing.</p><p>Sacituzumab govitecan (the active ingredient contained in Trodelvy) can cause severe diarrhea. Tell your doctor right away if you have:</p><ul>
<li>
<p>diarrhea (the first time it occurs);</p>
</li>
<li>
<p>diarrhea lasting longer than 24 hours (even if you use anti-diarrhea medicine);</p>
</li>
<li>
<p>black or bloody stools;</p>
</li>
<li>
<p>severe or ongoing vomiting, especially if you can't keep liquids down; or </p>
</li>
<li>
<p>a light-headed feeling, like you might pass out.</p>
</li>
</ul><p>diarrhea (the first time it occurs);</p><p>diarrhea lasting longer than 24 hours (even if you use anti-diarrhea medicine);</p><p>black or bloody stools;</p><p>severe or ongoing vomiting, especially if you can't keep liquids down; or </p><p>a light-headed feeling, like you might pass out.</p><p>Your cancer treatments may be delayed or permanently discontinued if you have certain side effects.</p><p>Common side effects may include:</p><ul>
<li>
<p>diarrhea, nausea, vomiting;</p>
</li>
<li>
<p>stomach pain, loss of appetite, constipation;</p>
</li>
<li>
<p>low blood cell counts;</p>
</li>
<li>
<p>rash;</p>
</li>
<li>
<p>hair loss; or</p>
</li>
<li>
<p>feeling tired.</p>
</li>
</ul><p>diarrhea, nausea, vomiting;</p><p>stomach pain, loss of appetite, constipation;</p><p>low blood cell counts;</p><p>rash;</p><p>hair loss; or</p><p>feeling tired.</p><p>This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. </p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to sacituzumab govitecan: intravenous powder for injection</i></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Hemoglobin decreased (93%), leukocytes decreased (91%), neutropenia (83%), activated partial thromboplastin time increased (60%), anemia (52%), platelets decreased (30%), thrombocytopenia (14%)<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Frequency not reported</b>: Immunogenicity</p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Back pain (23%), arthralgia (17%), pain in extremity (11%)<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Alkaline phosphatase increased (57%), magnesium decreased (51%), calcium decreased (49%), glucose increased (48%), aspartate aminotransferase increased (45%), albumin decreased (39%), alanine aminotransferase increased (35%), anorexia (30%), potassium decreased (30%), sodium decreased (25%), hyperglycemia (24%), hypomagnesemia (24%), hypokalemia (19%), glucose decreased (19%), hypophosphatemia (16%), dehydration (13%)<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Very common</b> (10% or more): Insomnia (13%)<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Very common</b> (10% or more): Urinary tract infection (21%)<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Respiratory infection (e.g., lower and upper respiratory tract infection, pneumonia, influenza, viral upper respiratory infection, bronchitis, respiratory syncytial virus infection) (26%), cough/productive cough (22%), dyspnea/exertional dyspnea (21%)<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Fatigue/asthenia (57%), edema (e.g., peripheral, localized, periorbital) (19%), pyrexia (14%)<sup>[Ref]</sup></p><h3>General</h3><p>The most frequent serious adverse reactions (reported in greater than 1%) of patients were febrile neutropenia (6%) vomiting (5%), nausea (3%), dyspnea (3%), diarrhea (4%), anemia (2%), pleural effusion, neutropenia, pneumonia, and dehydration.<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (23%), dizziness (22%), neuropathy (e.g., gait disturbance, hypoesthesia, muscular weakness, paresthesia, peripheral neuropathy, sensory neuropathy) (24%), dysgeusia (11%)<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Alopecia (38%), rash (e.g., maculopapular, erythematous, generalized rash, dermatitis acneiform, skin disorder, irritation, exfoliation) (31%), pruritus (17%), dry skin (15%)<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (69%), diarrhea (63%), vomiting (49%), constipation (34%), abdominal pain (e.g., abdominal pain, distention, upper abdominal pain, discomfort, tenderness) (26%), mucositis (e.g., stomatitis, esophagitis, mucosal inflammation) (14%)<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Trodelvy (sacituzumab govitecan)." Immunomedics, Morris Plains, NJ. </p><h2>More about Trodelvy (sacituzumab govitecan)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>Drug class: miscellaneous antineoplastics</li>
<li>FDA Approval History</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Trodelvy &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Breast Cancer</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>